Overview

Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease

Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
In the present study the investigators aim to determine the efficacy of an immunomodulating topical medication, compared with a topical lubricant, on the treatment of dry eye disease (DED) due to primary or secondary Sjögren's syndrome (aqueous deficient DED) and evaporative DED.
Phase:
Phase 4
Details
Lead Sponsor:
Federal University of São Paulo
Collaborator:
Allergan
Treatments:
Castor Oil
Cyclosporine
Cyclosporins